Ashraf Farishta, Individually and as Next Friend for Inaya Farishta v. Tenet Healthsystem Hospitals Dallas, Inc. D/B/A Trinity Medical Center

CourtCourt of Appeals of Texas
DecidedJanuary 25, 2007
Docket02-06-00188-CV
StatusPublished

This text of Ashraf Farishta, Individually and as Next Friend for Inaya Farishta v. Tenet Healthsystem Hospitals Dallas, Inc. D/B/A Trinity Medical Center (Ashraf Farishta, Individually and as Next Friend for Inaya Farishta v. Tenet Healthsystem Hospitals Dallas, Inc. D/B/A Trinity Medical Center) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ashraf Farishta, Individually and as Next Friend for Inaya Farishta v. Tenet Healthsystem Hospitals Dallas, Inc. D/B/A Trinity Medical Center, (Tex. Ct. App. 2007).

Opinion

                                               COURT OF APPEALS

                                                 SECOND DISTRICT OF TEXAS

                                                                FORT WORTH

                                        NO. 2-06-188-CV

ASHRAF FARISHTA, INDIVIDUALLY                                        APPELLANT

AND AS NEXT FRIEND FOR

INAYA FARISHTA                                                                               

                                                   V.

TENET HEALTHSYSTEM HOSPITALS                                         APPELLEE

DALLAS, INC. D/B/A TRINITY

MEDICAL CENTER                                                                              

                                              ------------

             FROM THE 16TH DISTRICT COURT OF DENTON COUNTY

                                             OPINION

I.  Introduction


In one issue, Appellant Ashraf Farishta (AAshraf@), Individually and as Next Friend for Inaya Farishta (AInaya@), asserts that the trial court abused its discretion, Aby looking beyond the four corners of the expert reports, in [an] effort to strike [P]laintiff=s expert reports under ' 74.351.@  See Tex. Civ. Prac. & Rem. Code Ann. ' 74.351 (Vernon Supp. 2006).  While we are not completely certain of the meaning of this issue in the context of the briefing, we agree that the trial court must look only to the four corners of the expert report to determine its adequacy.  See Bowie Mem=l Hosp. v. Wright, 79 S.W.3d 48, 52 (Tex. 2002).  We will construe the issue within the context of the briefing to mean the trial court abused its discretion in striking the Plaintiff=s expert reports for not meeting the statutory requirements.  See Tex. R. App. P. 38.9.  We reverse and remand to the trial court.

II.  Factual Background

This is the GBS case.  Ashraf gave birth to Inaya on August 4, 2003 at Trinity Medical Center (ATrinity@).  Inaya developed early onset Group B Streptococcus infection (AGBS@) at birth.  As a result of Inaya=s GBS infection, she developed multiple complications including respiratory distress, cyanosis, and pneumonia requiring intubation and prolonged hospitalization.

In August of 2002, one year prior to Inaya=s birth, the United States Government=s Centers for Disease Control (ACDC@) had published Clinical Practice Guidelines and Recommendations entitled APrevention of Perinatal Group B Streptococcal Disease.@  The CDC recommendations were based upon critical appraisal of multi-state population-based observational data and several studies from individual institutions.  The CDC Guidelines indicated the following:


Obstetric care [providers], in conjunction with supporting laboratories and labor and delivery facilities, should adopt the following strategy for the prevention of perinatal GBS disease based on prenatal screening for GBS colonization.  The risk-based approach is no longer an acceptable alternative except for circumstances in which screening results are not available before delivery.  All pregnant women should be screened at 35-37 weeks= gestation for vaginal and rectal GBS colonization.  At the time of labor or the rupture of membranes, intrapartum chemoprophylaxis should be given to all pregnant women identified as GBS carriers. [Emphasis supplied.]

The American College of Obstetricians and Gynecologists (AACOG@) adopted the CDC Recommendations and Guidelines, issuing the following statement:

The [ACOG] has issued new recommendations calling for universal screening of pregnant women for [GBS], a leading cause of illness and death among newborns in the United States.  Previously, ACOG and other experts had recommended two options for identifying women with GBS: either a culture screening at 35-37 weeks of pregnancy or assessment of clinical risk factors at the time of labor. . . .  The change in clinical practice follows new data and recommendations from the federal Centers for Disease Control and Prevention (CDC) that show routine prenatal screening is significantly more effective than the risk-based approach, resulting in far fewer cases of early-onset GBS disease in newborns (occurring during the first week of life).  In light of the new data, the risk-based strategy, except in certain circumstances, is no longer an acceptable alternative . . . .  The committee opinion supports the CDC=

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Barko v. Genzel
123 S.W.3d 457 (Court of Appeals of Texas, 2003)
American Transitional Care Centers of Texas, Inc. v. Palacios
46 S.W.3d 873 (Texas Supreme Court, 2001)
Windsor v. Maxwell
121 S.W.3d 42 (Court of Appeals of Texas, 2003)
Bowie Memorial Hospital v. Wright
79 S.W.3d 48 (Texas Supreme Court, 2002)
Flores v. Fourth Court of Appeals
777 S.W.2d 38 (Texas Supreme Court, 1989)
Longino v. Crosswhite Ex Rel. Crosswhite
183 S.W.3d 913 (Court of Appeals of Texas, 2006)
Downer v. Aquamarine Operators, Inc.
701 S.W.2d 238 (Texas Supreme Court, 1985)

Cite This Page — Counsel Stack

Bluebook (online)
Ashraf Farishta, Individually and as Next Friend for Inaya Farishta v. Tenet Healthsystem Hospitals Dallas, Inc. D/B/A Trinity Medical Center, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ashraf-farishta-individually-and-as-next-friend-fo-texapp-2007.